Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

RIPK1 is a critical mediator of cell death and inflammation downstream of TNFR1 upon stimulation by TNFα, a potent proinflammatory cytokine involved in a multitude of human inflammatory and degenerative diseases. RIPK1 contains an N-terminal kinase domain, an intermediate domain, and a C-terminal de...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 115; no. 9; pp. E2001 - E2009
Main Authors Meng, Huyan, Liu, Zhen, Li, Xingyan, Wang, Huibing, Jin, Taijie, Wu, Guowei, Shan, Bing, Christofferson, Dana E., Qi, Chunting, Yu, Qiang, Li, Ying, Yuan, Junying
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 27.02.2018
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:RIPK1 is a critical mediator of cell death and inflammation downstream of TNFR1 upon stimulation by TNFα, a potent proinflammatory cytokine involved in a multitude of human inflammatory and degenerative diseases. RIPK1 contains an N-terminal kinase domain, an intermediate domain, and a C-terminal death domain (DD). The kinase activity of RIPK1 promotes cell death and inflammation. Here, we investigated the involvement of RIPK1-DD in the regulation of RIPK1 kinase activity. We show that a charge-conserved mutation of a lysine located on the surface of DD (K599R in human RIPK1 or K584R in murine RIPK1) blocks RIPK1 activation in necroptosis and RIPK1-dependent apoptosis and the formation of complex II. Ripk1K584R/K584R knockin mutant cells are resistant to RIPK1 kinase-dependent apoptosis and necroptosis. The resistance of K584R cells, however, can be overcome by forced dimerization of RIPK1. Finally, we show that the K584R RIPK1 knockin mutation protects mice against TNFα-induced systematic inflammatory response syndrome. Our study demonstrates the role of RIPK1-DD in mediating RIPK1 dimerization and activation of its kinase activity during necroptosis and RIPK1-dependent apoptosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed by Junying Yuan, January 22, 2018 (sent for review December 19, 2017; reviewed by Jiahuai Han and Adrian T. Ting)
Author contributions: Y.L. and J.Y. designed research; H.M., Z.L., X.L., H.W., T.J., G.W., B.S., D.E.C., C.Q., and Y.L. performed research; Q.Y. contributed new reagents/analytic tools; H.M., Y.L., and J.Y. analyzed data; and H.M., Y.L., and J.Y. wrote the paper.
Reviewers: J.H., Xiamen University; and A.T.T., Icahn School of Medicine at Mount Sinai.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1722013115